ES2196595T3 - Polihidroxibutilpirazinas, su preparacion y medicantes que los contienen. - Google Patents

Polihidroxibutilpirazinas, su preparacion y medicantes que los contienen.

Info

Publication number
ES2196595T3
ES2196595T3 ES98939677T ES98939677T ES2196595T3 ES 2196595 T3 ES2196595 T3 ES 2196595T3 ES 98939677 T ES98939677 T ES 98939677T ES 98939677 T ES98939677 T ES 98939677T ES 2196595 T3 ES2196595 T3 ES 2196595T3
Authority
ES
Spain
Prior art keywords
sub
radical
represent
methylene
choh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98939677T
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2196595T3 publication Critical patent/ES2196595T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención se refiere a medicamentos que contienen, como principio activo, al menos un compuesto de fórmula (I) en el que: tanto (A) R{sub,9} y R{sub,10} representan cada uno un radical -CH{sub,2}OH y cada R{sub,3} representa un radical metileno, R{sub,4} representa un radical -CHOH- y uno de los radicales R{sub,1}, R{sub,2}, R{sub,5} y R{sub,6} representan un radical carbonilo, metileno, -CHF-, -CH{(}NHR{sub,7}{- o -CH{(}OR{sub,8}{ y los otros representan cada uno un radical -CHOH- o R{sub,2} y R{sub,5} representan cada uno un radical -CHOH-, R{sub,3} representa un radical metileno y R{sub,1}, R{sub,4} y R{sub,6} son idénticos y representan cada uno carbonilo, metileno, -CHF-, -CH{(}NHR{sub,7}{- o -CH{(}OR{sub,8}{, o R{sub,1} y R{sub,6} representan cada uno un radical -CHOH-, R{sub,3} representa un radical metileno y R{sub,2}, R{sub,4} y R{sub,5} son idénticos y representan cada uno un radical carbonilo, metileno, -CHF-, -CH{(}NHR{sub,7}{- o un radical -CH{(}OR{sub,8}{, o R{sub,1}, R{sub,4}, R{sub,5} y R{sub,6} representan, cada uno, un radical -CHOH- y -R{sub,2}-R{sub,3}- representa un -CH=CH-; o (B) R{sub,1}, R{sub,2}, R{sub,4}, R{sub,5} y R{sub,6} representan, cada uno, un radical -CHOH-, R{sub,3} representa un radical metileno, R{sub,9} representa un radical -CH{sub,2}F o -CH{sub,2}OH, R{sub,10} representa un -CH{sub,2}F o -CH{sub,2}OH, con tal que R{sub,9} y R{sub,10} no sean ambos un radical -CH{sub,2}OH o uno de sus estereoisómeros o una sal de dicho compuesto; los nuevos compuestos de fórmula (I) y el procedimiento para prepararlos.
ES98939677T 1997-07-17 1998-07-15 Polihidroxibutilpirazinas, su preparacion y medicantes que los contienen. Expired - Lifetime ES2196595T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation

Publications (1)

Publication Number Publication Date
ES2196595T3 true ES2196595T3 (es) 2003-12-16

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98939677T Expired - Lifetime ES2196595T3 (es) 1997-07-17 1998-07-15 Polihidroxibutilpirazinas, su preparacion y medicantes que los contienen.

Country Status (25)

Country Link
US (1) US6288066B1 (es)
EP (1) EP1001942B1 (es)
JP (1) JP4443033B2 (es)
KR (1) KR20010021871A (es)
CN (1) CN1264368A (es)
AT (1) ATE243683T1 (es)
AU (1) AU745905B2 (es)
BR (1) BR9810595A (es)
CA (1) CA2296725C (es)
CZ (1) CZ290896B6 (es)
DE (1) DE69815854T2 (es)
DK (1) DK1001942T3 (es)
ES (1) ES2196595T3 (es)
FR (1) FR2766183B1 (es)
HU (1) HUP0004661A3 (es)
IL (1) IL134039A0 (es)
MX (1) MXPA00000437A (es)
NO (1) NO20000199L (es)
NZ (1) NZ502279A (es)
PL (1) PL338147A1 (es)
PT (1) PT1001942E (es)
RU (1) RU2186773C2 (es)
SK (1) SK462000A3 (es)
WO (1) WO1999003841A1 (es)
ZA (1) ZA986336B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
WO2008122329A1 (en) * 2007-03-19 2008-10-16 Dsm Ip Assets B.V. Uv-filter compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
DK1001942T3 (da) 2003-10-20
MXPA00000437A (es) 2002-04-17
DE69815854T2 (de) 2004-05-13
HUP0004661A2 (hu) 2001-11-28
CZ290896B6 (cs) 2002-11-13
CN1264368A (zh) 2000-08-23
JP4443033B2 (ja) 2010-03-31
AU745905B2 (en) 2002-04-11
ZA986336B (en) 1999-01-27
US6288066B1 (en) 2001-09-11
NO20000199D0 (no) 2000-01-14
BR9810595A (pt) 2000-09-12
PT1001942E (pt) 2003-11-28
ATE243683T1 (de) 2003-07-15
SK462000A3 (en) 2000-06-12
PL338147A1 (en) 2000-09-25
CZ2000121A3 (cs) 2000-05-17
WO1999003841A1 (fr) 1999-01-28
NZ502279A (en) 2002-04-26
NO20000199L (no) 2000-01-14
IL134039A0 (en) 2001-04-30
FR2766183B1 (fr) 1999-08-27
JP2001510185A (ja) 2001-07-31
EP1001942B1 (fr) 2003-06-25
FR2766183A1 (fr) 1999-01-22
KR20010021871A (ko) 2001-03-15
CA2296725A1 (fr) 1999-01-28
DE69815854D1 (de) 2003-07-31
CA2296725C (fr) 2008-11-18
HUP0004661A3 (en) 2001-12-28
AU8810398A (en) 1999-02-10
RU2186773C2 (ru) 2002-08-10
EP1001942A1 (fr) 2000-05-24

Similar Documents

Publication Publication Date Title
FI833748A (fi) Immunogent protein- eller peptidkomplex, saett foer framstaellning och anvaendning daerav som immunstimulerande medel och saosom vaccin
FI865233A (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
ES531978A0 (es) Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona.
WO1999063826A3 (de) Mittel zur bekämpfung von pflanzenschädlingen
ES2053451T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
UY28946A1 (es) Compuestos de aril-y heteroaril-alquilanina que contienen pirazol, composiciones farmacéuticas que contienen los compuestos y nuevos productos químicos intermedios
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
AR003415A1 (es) Compuestos analogos de lactacistina, metodo para inhibir la proteolisis dependiente de proteasoma, metodo para identificar un proceso biologico mediado por proteolisis dependiente de proteasoma, uso de dichos compuestos para preparar un medicamento para tratar una condicion mediada por proteolisis dependiente de proteasoma.
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
TR200201102T2 (tr) Yeni oligosakkaritler, bunların hazırlanması ve bunları içeren ilaç bileşimleri
ATE300541T1 (de) Pyrazolopyridinderivate
ECSP034766A (es) Una combinacion que comprende combretastatina y agentes anticancerigenos
DK0973544T3 (da) Immuntolerant prothrombinkomplekspræparat
AR001738A1 (es) Preparados en forma de capsulas para el tratamiento de plantas y método para administrar compuestos biologicamente activos a plantas
DK0456209T3 (da) Bis(alkylsubstituerede-4-hydroxyphenylthio)alkananaloger som inhibitorer af kataraktdannelse
ES525574A0 (es) Procedimiento para producir preparaciones farmaceuticas que contienen como substancias activas derivados de polialquilenglicol.
MX9301527A (es) Composiciones de acido n-(fosfonoacetil)-l-aspartico y metodo para sus usos como agentes antivirales de amplio espectro.
ES2196595T3 (es) Polihidroxibutilpirazinas, su preparacion y medicantes que los contienen.
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
BRPI0606137A2 (pt) composto e uso do mesmo
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
FI873313A0 (fi) 2-acyloxipropylaminderivat, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
ES534414A0 (es) Un procedimiento para preparar pirazolo (3, 4, 5-kl) acridinas
DE69829849D1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen